Targeted Therapy
The management of lung cancer has been transformed by the advent of next
generation sequencing leading to identification of therapeutic targets
resulting in better clinical outcomes compared to patients with absence
of molecular targets. [9] Therefore molecular testing for treatable
oncogenic alterations should be implemented as an essential part of
diagnostic testing before deciding treatment plan for a patient with
newly diagnosed NSCLC.[22,23]